Table 1.

Demographic information and baseline laboratory findings in silymarin and placebo groups

Variables	Mean ± SD or n (%)		P-value
	Silymarin group	Placebo group
Sex
Male	25 (55.6)	21 (46.7)	0.52
Female	20 (44.4)	24 (53.3)
Age (years)	52.02 ±14.92	54.15 ±17.38	0.53
Weight (kg)	65.66 ±12.67	67.22 ±10.59	0.53
APACHE II score	14.48 ±4.92	14.60 ±4.64	0.91
Mg (mg/dl)	1.59 ±0.42	1.61 ±0.49	0.85
Na (mEq/l)	138.37 ±2.41	138.84 ±2.90	0.41
K (mEq/l)	4.30 ±0.67	4.27 ±0.50	0.80
Ca (mg/l)	8.63 ±0.48	8.58 ±0.57	0.60
Albumin (g/dl)	3.34 ±0.49	3.26 ±0.65	0.50
Direct bilirubin (mg/dl)	0.4 ±0.21	0.43 ±0.19	0.54
INR	1.21 ±0.21	1.22 ±0.21	0.72
Serum creatinine	1.47 ±81	1.42 ±67	0.76
BUN	21.02 ±7.47	21.08 ±5.90	0.96

SD – standard deviation, APACHE II score – Acute Physiology and Chronic Health Evaluation II Score, INR – international normalized ratio, BUN – blood urea nitrogen